Collaborating with our partner, a renowned Big Data provider, to integrate with our SaaS and SaMD template platforms is expected to ... medication to OTC first involves the design of a Drug Facts ...

Collaborating with our partner, a renowned Big Data provider, to integrate with our SaaS and SaMD template platforms ... involves the design of a Drug Facts Label ("DFL") that is well understood ...

Schreiner MediPharm’s new Digital Display Label allows trial sponsors to eliminate time-consuming manual relabeling.

House Bill 12 would generally allow a doctor to prescribe any drug, even if it is for off-label use, and require a pharmacist to dispense it. An off-label drug is when it is prescribed for a purpose ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› By Katie Okamoto Katie Okamoto is an editor focusing on sustainability. She’s covered ...